These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 12880968)
1. Negative autoregulation of p73 and p53 by DeltaNp73 in regulating differentiation and survival of human neuroblastoma cells. Nakagawa T; Takahashi M; Ozaki T; Watanabe K; Hayashi S; Hosoda M; Todo S; Nakagawara A Cancer Lett; 2003 Jul; 197(1-2):105-9. PubMed ID: 12880968 [TBL] [Abstract][Full Text] [Related]
3. Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter. Nakagawa T; Takahashi M; Ozaki T; Watanabe Ki K; Todo S; Mizuguchi H; Hayakawa T; Nakagawara A Mol Cell Biol; 2002 Apr; 22(8):2575-85. PubMed ID: 11909952 [TBL] [Abstract][Full Text] [Related]
4. Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line. Goldschneider D; Blanc E; Raguénez G; Barrois M; Legrand A; Le Roux G; Haddada H; Bénard J; Douc-Rasy S J Cell Sci; 2004 Jan; 117(Pt 2):293-301. PubMed ID: 14676279 [TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase inhibitors differentially modulate p73 isoforms in neuroblastoma. Lau LM; Wolter JK; Lau JT; Cheng LS; Smith KM; Hansford LM; Zhang L; Baruchel S; Robinson F; Irwin MS Oncogene; 2009 May; 28(19):2024-33. PubMed ID: 19363520 [TBL] [Abstract][Full Text] [Related]
6. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. Zaika AI; Slade N; Erster SH; Sansome C; Joseph TW; Pearl M; Chalas E; Moll UM J Exp Med; 2002 Sep; 196(6):765-80. PubMed ID: 12235210 [TBL] [Abstract][Full Text] [Related]
7. Spatiotemporal switch from DeltaNp73 to TAp73 isoforms during nephrogenesis: impact on differentiation gene expression. Saifudeen Z; Diavolitsis V; Stefkova J; Dipp S; Fan H; El-Dahr SS J Biol Chem; 2005 Jun; 280(24):23094-102. PubMed ID: 15805112 [TBL] [Abstract][Full Text] [Related]
8. The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells. Goldschneider D; Million K; Meiller A; Haddada H; Puisieux A; Bénard J; May E; Douc-Rasy S J Cell Sci; 2005 Mar; 118(Pt 6):1245-53. PubMed ID: 15741235 [TBL] [Abstract][Full Text] [Related]
9. Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73. Ishimoto O; Kawahara C; Enjo K; Obinata M; Nukiwa T; Ikawa S Cancer Res; 2002 Feb; 62(3):636-41. PubMed ID: 11830511 [TBL] [Abstract][Full Text] [Related]
10. TAp73 and ΔNp73 have opposing roles in 5-aza-2'-deoxycytidine-induced apoptosis in breast cancer cells. Lai J; Yang F; Zhang W; Wang Y; Xu J; Song W; Huang G; Gu J; Guan X Mol Cells; 2014 Aug; 37(8):605-12. PubMed ID: 25134538 [TBL] [Abstract][Full Text] [Related]
11. When p53 needs p73 to be functional - forced p73 expression induces nuclear accumulation of endogenous p53 protein. Goldschneider D; Blanc E; Raguenez G; Haddada H; Bénard J; Douc-Rasy S Cancer Lett; 2003 Jul; 197(1-2):99-103. PubMed ID: 12880967 [TBL] [Abstract][Full Text] [Related]
12. Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function. Watson IR; Blanch A; Lin DC; Ohh M; Irwin MS J Biol Chem; 2006 Nov; 281(45):34096-103. PubMed ID: 16980297 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of induction of apoptosis by p73 and its relevance to neuroblastoma biology. Rossi M; Sayan AE; Terrinoni A; Melino G; Knight RA Ann N Y Acad Sci; 2004 Dec; 1028():143-9. PubMed ID: 15650240 [TBL] [Abstract][Full Text] [Related]
14. p73 induces apoptosis by different mechanisms. Ramadan S; Terrinoni A; Catani MV; Sayan AE; Knight RA; Mueller M; Krammer PH; Melino G; Candi E Biochem Biophys Res Commun; 2005 Jun; 331(3):713-7. PubMed ID: 15865927 [TBL] [Abstract][Full Text] [Related]
15. E1A activates transcription of p73 and Noxa to induce apoptosis. Flinterman M; Guelen L; Ezzati-Nik S; Killick R; Melino G; Tominaga K; Mymryk JS; Gäken J; Tavassoli M J Biol Chem; 2005 Feb; 280(7):5945-59. PubMed ID: 15572378 [TBL] [Abstract][Full Text] [Related]
16. Transactivation-dependent and -independent regulation of p73 stability. Dulloo I; Sabapathy K J Biol Chem; 2005 Aug; 280(31):28203-14. PubMed ID: 15919663 [TBL] [Abstract][Full Text] [Related]
17. Differential control of TAp73 and DeltaNp73 protein stability by the ring finger ubiquitin ligase PIR2. Sayan BS; Yang AL; Conforti F; Tucci P; Piro MC; Browne GJ; Agostini M; Bernardini S; Knight RA; Mak TW; Melino G Proc Natl Acad Sci U S A; 2010 Jul; 107(29):12877-82. PubMed ID: 20615966 [TBL] [Abstract][Full Text] [Related]
18. Differential regulation of p73 variants in response to cisplatin treatment in SH-SY5Y neuroblastoma cells. Million K; Horvilleur E; Goldschneider D; Agina M; Raguénez G; Tournier F; Bénard J; Douc-Rasy S Int J Oncol; 2006 Jul; 29(1):147-54. PubMed ID: 16773194 [TBL] [Abstract][Full Text] [Related]
19. Dysregulation of platelet-derived growth factor beta-receptor expression by DeltaNp73 in neuroblastoma. Wetterskog D; Moshiri A; Ozaki T; Uramoto H; Nakagawara A; Funa K Mol Cancer Res; 2009 Dec; 7(12):2031-9. PubMed ID: 19952113 [TBL] [Abstract][Full Text] [Related]
20. Differential regulation of p63 and p73 expression. Waltermann A; Kartasheva NN; Dobbelstein M Oncogene; 2003 Aug; 22(36):5686-93. PubMed ID: 12944917 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]